SEC Form 4 · accession 0001209191-16-104325
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Martha J Demski
Director
Period of report
Mar 1, 2016
Accepted (ET)
Mar 2, 2016 · 2:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2016 | P | 10,000 | $4.89 | A | 10,000 | D | |
| Common Stock | holding | — | — | — | 14,788 | I | By the Martha J. Demski Trust u/a 10/01/94 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The range of purchase prices paid is $4.89 to $4.90. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.